☆Grant523 days leftClinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)synopsis · Status: posted · Opportunity #PAR-25-145AgencyNational Institutes of HealthGrants.gov· Posted Nov 6, 2024#PAR-25-145
☆Grant449 days leftCancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)synopsis · Status: posted · Opportunity #PAR-25-103AgencyNational Institutes of HealthGrants.gov· Posted Nov 5, 2024#PAR-25-103
☆Grant523 days leftDissemination and Implementation Research in Health (R21 Clinical Trial Optional)synopsis · Status: posted · Opportunity #PAR-25-143AgencyNational Institutes of HealthGrants.gov· Posted Oct 31, 2024#PAR-25-143
☆Grant523 days leftDissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)synopsis · Status: posted · Opportunity #PAR-25-233AgencyNational Institutes of HealthGrants.gov· Posted Oct 30, 2024#PAR-25-233
☆Grant523 days leftDissemination and Implementation Research in Health (R01 Clinical Trial Optional)synopsis · Status: posted · Opportunity #PAR-25-144AgencyNational Institutes of HealthGrants.gov· Posted Oct 29, 2024#PAR-25-144
☆Past award151 days leftHEALTHEQUITY, INC. — IN ACCORDANCE WITH THE ATTACHED INVOICE (TASK ORDER REQUEST) DATED FEBRUARY 19TH, 2026 ANDIN ACCORDANCE WITH THE ATTACHED INVOICE (TASK ORDER REQUEST) DATED FEBRUARY 19TH, 2026 AND THE ATTACHED FSA HEALTH EQUITY ADMINISTRATIVE FEES CHART FOR 2026, AND FOR A HEREBY-FUNDED TOTAL FIXED-PRICE OF $10,999.69, AND DURING THE ONE-YEAR TIME-PERIODAgencyDepartment of TransportationNAICS524292 · PHARMACY BENEFIT MANAGEMENT AND OTHER THIRD PARTY ADMINISTRATION OF INSURANCE AND PENSION FUNDSPlaceDCValue$10KUSASpending.gov· Posted Dec 1, 2026#693JK426F55007N
☆Contract8 days leftInstall, Configure, Provide Maintenance, Repair and Training Services for an Electronic Security System (ESS) to Include Access Control System (ACS) and Closed Circuit Television System (CCTV) for Outlying Hospital Clinics (OHCs), Behavior Health (BH)AgencyDEPT OF DEFENSENAICS561621SAM.gov· Posted Jul 31, 2026#W91QVN26RA032
☆ContractSBA Certified Women-Owned Small Business (WOSB) Program Set-Aside (FAR 19.15)1 day leftTransportation of Blood Products for Infusion and Patient SpecimensThe Gallup Indian Medical Center has a requirement for transportation of blood products for infusion and patient specimens. Quotes are due: DATE: 8/3/2026 TIME: 11:00 am MDT LOCATION: Via email at Misty.Billy@ihs.govAgencyHEALTH AND HUMAN SERVICES, DEPARTMENT OFNAICS492110PlaceGallup, NMSAM.gov· Posted Jul 28, 2026#75H71026Q00213
☆ContractService-Disabled Veteran-Owned Small Business (SDVOSB) Set-Aside (FAR 19.14)29 days leftThe VA North Texas Health Care system requires community based Outpatient clinic (CBOC))AgencyVETERANS AFFAIRS, DEPARTMENT OFNAICS621498PlaceDallas, TXSAM.gov· Posted Jul 28, 2026#36C25726R0018
☆ContractNo Set aside used5 days leftClinical Laboratory Testing and Specialized Biochemical AnalysisServices for the NHGRI Undiagnosed Diseases Program (UDP) through Baylor Genetics LaboratoryAgencyHEALTH AND HUMAN SERVICES, DEPARTMENT OFNAICS621511PlaceBethesda, MDSAM.gov· Posted Jul 28, 2026#75N98026Q00900
☆Contract8a Competed93 days leftOCONUS Medical Q-Coded ServicesThe purpose of this amendment is to respond to Direct Patient Care and Mental Health Offeror questions and provide updated attachments and technical exhibits as applicable.All other terms and conditions remain the same. The points of contact (POCs) for this amendment are Ms. Kenyadah Gamble at kenyadah.m.gamble.civ@health.mil or 667-892-3554, Ms. Shannon La Com at shannon.lacom2.civ@health.mil or 667-892-3558, and Mr. Pedro Reyes at pedro.a.reyes10.civ@health.mil or 210-792-5689.AgencyDEPT OF DEFENSENAICS621111 · Offices of PhysiciansSAM.gov· Posted Jun 5, 2026#HT941026R2000
☆Grant644 days leftNIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed)synopsis · Status: posted · Opportunity #PAR-25-333AgencyNational Institutes of HealthGrants.gov· Posted Jun 17, 2025#PAR-25-333
☆Grant544 days leftBlueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)synopsis · Status: posted · Opportunity #PAR-25-383AgencyNational Institutes of HealthGrants.gov· Posted Jun 17, 2025#PAR-25-383
☆Grant767 days leftSupport for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed)synopsis · Status: posted · Opportunity #PAR-25-415AgencyNational Institutes of HealthGrants.gov· Posted Jun 13, 2025#PAR-25-415
☆Grant767 days leftSupport for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)synopsis · Status: posted · Opportunity #PAR-25-414AgencyNational Institutes of HealthGrants.gov· Posted Jun 13, 2025#PAR-25-414
☆Grant316 days leftNIGMS National and Regional Resources (R24 - Clinical Trial Not Allowed)synopsis · Status: posted · Opportunity #PAR-25-416AgencyNational Institutes of HealthGrants.gov· Posted Jun 11, 2025#PAR-25-416
☆Grant250 days leftShort Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 Clinical Trials Not Allowed)synopsis · Status: posted · Opportunity #RFA-OD-25-003AgencyNational Institutes of HealthGrants.gov· Posted Mar 12, 2025#RFA-OD-25-003
☆Grant108 days leftEthical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)synopsis · Status: posted · Opportunity #PAR-25-369AgencyNational Institutes of HealthGrants.gov· Posted Jan 13, 2025#PAR-25-369
☆Grant106 days leftEthical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)synopsis · Status: posted · Opportunity #PAR-25-370AgencyNational Institutes of HealthGrants.gov· Posted Jan 13, 2025#PAR-25-370
☆Grant108 days leftEthical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)synopsis · Status: posted · Opportunity #PAR-25-371AgencyNational Institutes of HealthGrants.gov· Posted Jan 13, 2025#PAR-25-371